tiprankstipranks
Trending News
More News >
OMRON Corporation (JP:6645)
:6645
Advertisement

OMRON (6645) AI Stock Analysis

Compare
5 Followers

Top Page

JP:6645

OMRON

(OTC:6645)

Rating:66Neutral
Price Target:
¥4,177.00
▲(8.55% Upside)
OMRON's overall stock score is driven primarily by its stable financial performance, supported by a strong balance sheet and cash flow generation. Technical analysis indicates a neutral trend with potential for upward momentum, while valuation metrics suggest moderate pricing. The absence of earnings call insights and corporate events limits additional context.

OMRON (6645) vs. iShares MSCI Japan ETF (EWJ)

OMRON Business Overview & Revenue Model

Company DescriptionOMRON Corporation engages in industrial automation, electronic and mechanical components, social systems, and healthcare businesses worldwide. The company's Industrial Automation Business offers sensors, switches, safety and control components, relays, automation systems, motion/drives, robotics, energy conservation support/environment measure equipment, and power supplies. Its Electronic and Mechanical Components Business provides relays, switches, connectors, sensors, and components/units for amusement equipment. The company's Social Systems, Solutions and Service Business offers terminals and systems, including PV inverters and storage batteries; railway station systems, such as automated ticket gates and ticket vending machines, traffic and road management systems, payment systems, and UPS that protect equipment from unexpected power disruption; a range of solutions comprising software development and maintenance services to support the social infrastructure; and transport management systems and infrastructure monitoring systems. Its Healthcare Business offers blood pressure monitors; nebulizers; electrotherapy TENS devices; digital thermometers; body composition monitors; and other products, such as activity monitors, AEDs, etc. OMRON Corporation has an agreement with JMDC Inc. to jointly develop personalized aggravation and nursing care prevention solutions that support prescription medication treatments and patient lifestyle changes by predicting the risk of the onset of individual patient events. The company was formerly known as OMRON Tateisi Electronics Co. and changed its name to OMRON Corporation in January 1990. OMRON Corporation was founded in 1933 and is headquartered in Kyoto, Japan.
How the Company Makes MoneyOMRON Corporation generates revenue primarily through the sale of its diverse range of products and solutions across its key business segments. The Industrial Automation segment is a major revenue generator, providing automation systems and solutions that improve production efficiency and quality for various industries. The Healthcare segment contributes significantly through sales of medical devices, such as blood pressure monitors and nebulizers, which are popular worldwide. Additionally, the Electronic and Mechanical Components segment earns revenue by supplying essential components to various industries, including automotive and consumer electronics. Strategic partnerships and collaborations with other technological leaders and a strong global distribution network further bolster OMRON's earnings, allowing the company to penetrate new markets and enhance its technological offerings.

OMRON Financial Statement Overview

Summary
OMRON exhibits a stable financial foundation with solid balance sheet metrics and cash flow generation. However, income statement metrics indicate challenges in revenue and profitability growth, suggesting a need for strategic adjustments to sustain growth momentum.
Income Statement
72
Positive
The company has shown resilience with a moderate gross profit margin and a stable net profit margin. However, the revenue growth shows fluctuations, with a recent decline. EBIT and EBITDA margins have faced downward pressure, affecting overall profitability.
Balance Sheet
80
Positive
The balance sheet is strong, characterized by a sound equity ratio and a favorable debt-to-equity ratio. Return on equity remains solid, indicating effective use of shareholders' equity, despite the challenges in revenue growth.
Cash Flow
68
Positive
Operating cash flow remains robust, supporting cash flow stability. However, free cash flow has seen variability, with a recent recovery. The operating cash flow to net income ratio highlights efficient cash conversion.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue801.75B818.76B876.08B762.93B655.53B
Gross Profit357.14B346.46B393.88B346.83B298.35B
EBITDA62.45B65.77B125.00B110.08B87.84B
Net Income16.27B8.11B73.86B61.40B43.31B
Balance Sheet
Total Assets1.36T1.35T998.16B930.63B820.38B
Cash, Cash Equivalents and Short-Term Investments149.02B143.09B105.28B155.48B250.75B
Total Debt144.31B172.76B45.37B60.12B38.89B
Total Liabilities387.47B403.74B266.93B262.66B211.02B
Stockholders Equity771.88B786.69B728.47B665.23B606.86B
Cash Flow
Free Cash Flow6.79B-503.00M8.44B34.07B67.17B
Operating Cash Flow55.78B44.88B53.46B67.43B93.83B
Investing Cash Flow-47.89B-107.10B-55.53B-150.16B-14.79B
Financing Cash Flow-4.61B85.99B-58.76B-29.60B-20.35B

OMRON Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3848.00
Price Trends
50DMA
3824.10
Positive
100DMA
3942.80
Negative
200DMA
4461.60
Negative
Market Momentum
MACD
5.67
Positive
RSI
49.50
Neutral
STOCH
46.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6645, the sentiment is Negative. The current price of 3848 is below the 20-day moving average (MA) of 3865.25, above the 50-day MA of 3824.10, and below the 200-day MA of 4461.60, indicating a neutral trend. The MACD of 5.67 indicates Positive momentum. The RSI at 49.50 is Neutral, neither overbought nor oversold. The STOCH value of 46.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6645.

OMRON Peers Comparison

Overall Rating
UnderperformOutperform
Sector (50)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$757.40B23.164.20%2.63%1.05%
50
Neutral
AU$1.64B1.17-0.63%3.34%15.80%-4.23%
$3.49B36.294.46%3.47%
$4.20B20.418.68%2.85%
$6.83B18.287.69%1.80%
$6.99B20.6010.54%1.74%
$3.85B16.4413.68%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6645
OMRON
3,947.00
-1,251.25
-24.07%
HPHTF
Hamamatsu Photonics KK
11.30
-1.45
-11.37%
HRSEF
HIROSE ELECTRIC CO
127.34
9.26
7.84%
MNBEF
MinebeaMitsumi
17.38
-3.29
-15.92%
SHMZF
Shimadzu
24.25
-7.09
-22.62%
TOKCF
Tokyo Ohka Kogyo Co
24.76
-1.04
-4.03%

OMRON Corporate Events

OMRON Corporation Reports Q1 FY2025 Revenue Growth Amid Tariff Challenges
Aug 6, 2025

OMRON Corporation reported an increase in consolidated revenue and profit in Q1 FY2025, despite challenges from U.S. tariff policies. The Industrial Automation Business (IAB) and Device & Module Solutions Business (DMB) experienced growth, while the Healthcare Business (HCB) faced declines due to a market slowdown in China. The company remains cautious about the future due to ongoing tariff uncertainties but is progressing with initiatives to enhance competitiveness and profitability.

The most recent analyst rating on (JP:6645) stock is a Buy with a Yen6000.00 price target. To see the full list of analyst forecasts on OMRON stock, see the JP:6645 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 15, 2025